Inovio Pharmaceuticals Inc (INO)
11.12
-0.76
(-6.44%)
USD |
NASDAQ |
May 07, 16:00
11.11
0.00 (0.00%)
After-Hours: 20:00
Inovio Pharmaceuticals Revenue (Quarterly): 0.1027M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.1027M |
| September 30, 2023 | 0.3884M |
| June 30, 2023 | 0.226M |
| March 31, 2023 | 0.1149M |
| December 31, 2022 | 0.1247M |
| September 30, 2022 | 9.154M |
| June 30, 2022 | 0.7844M |
| March 31, 2022 | 0.1991M |
| December 31, 2021 | 0.8391M |
| September 30, 2021 | 0.2917M |
| June 30, 2021 | 0.2728M |
| March 31, 2021 | 0.3711M |
| December 31, 2020 | 5.581M |
| September 30, 2020 | 0.2362M |
| June 30, 2020 | 0.2672M |
| March 31, 2020 | 1.327M |
| December 31, 2019 | 0.2795M |
| September 30, 2019 | 0.8669M |
| June 30, 2019 | 0.1357M |
| March 31, 2019 | 2.830M |
| December 31, 2018 | 2.503M |
| September 30, 2018 | 2.001M |
| June 30, 2018 | 24.45M |
| March 31, 2018 | 1.530M |
| December 31, 2017 | 8.787M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.644M |
| June 30, 2017 | 20.41M |
| March 31, 2017 | 10.38M |
| December 31, 2016 | 8.514M |
| September 30, 2016 | 12.54M |
| June 30, 2016 | 6.204M |
| March 31, 2016 | 8.110M |
| December 31, 2015 | 5.936M |
| September 30, 2015 | 24.18M |
| June 30, 2015 | 5.287M |
| March 31, 2015 | 5.167M |
| December 31, 2014 | 2.457M |
| September 30, 2014 | 1.840M |
| June 30, 2014 | 3.802M |
| March 31, 2014 | 2.358M |
| December 31, 2013 | 1.740M |
| September 30, 2013 | 9.487M |
| June 30, 2013 | 0.7856M |
| March 31, 2013 | 1.455M |
| December 31, 2012 | 1.135M |
| September 30, 2012 | 0.8547M |
| June 30, 2012 | 0.4361M |
| March 31, 2012 | 1.693M |
| December 31, 2011 | 1.633M |
| September 30, 2011 | 2.638M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.1027M
Minimum
Dec 2023
9.154M
Maximum
Sep 2022
1.135M
Average
0.2795M
Median
Dec 2019
Revenue (Quarterly) Benchmarks
| Cerus Corp | 38.36M |
| Stereotaxis Inc | 4.565M |
| Viemed Healthcare Inc | 50.74M |
| AIM ImmunoTech Inc | 0.065M |
| Protalix BioTherapeutics Inc | 10.49M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.00M |
| Total Expenses (Quarterly) | 27.50M |
| EPS Diluted (Quarterly) | -1.05 |
| Enterprise Value | 131.24M |
| Profit Margin (Quarterly) | -24.36K% |
| Earnings Yield | -54.79% |
| Normalized Earnings Yield | -52.96 |